abstract |
The present invention relates to novel compounds having the general formula (I), wherein R 1 to R 6 , W, and X are as described herein and their pharmaceutically acceptable salts. , Enantiomers or diastereomers, and compositions comprising the compounds and methods of using the compounds are provided. |